ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in St Louis, MO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Small Cell Lung Carcinoma
Cancer
Colorectal Cancer
Neoplasm Metastasis
Squamous Cell Carcinoma of Head and Neck
Breast Cancer

Lung Cancer trials near St Louis, MO, USA:

Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)

Although small cell lung cancer (SCLC) responds dramatically to initial platinum-based chemotherapy, recurrences are nearly univers...

Enrolling
Small-cell Lung Cancer
Small Cell Lung Cancer
Drug: Cirtuvivint
Drug: Irinotecan

Phase 1, Phase 2

The Washington University
The Washington University

St Louis, Missouri, United States

Status recently updated

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

Inhibitor( TKI) , to recurrent, advanced, or metastatic small cell lung cancer (SCLC) patients , Non-Small Cell Lung (NSCL...

Active, not recruiting
Enrolling
Small Cell Lung Cancer
Non-Small Cell Lung
Drug: AL8326 40 mg
Drug: AL8326 60 mg

Phase 2

Advenchen

St Louis, Missouri, United States and 6 other locations

Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung Cancer

(CT-STAR) to central and ultra-central early-stage non-small cell lung cancers on grade 3 or greater toxicity. Online adaptive radi...

Active, not recruiting
Non-small Cell Lung Cancer
Early Stage Non-small Cell Lung Cancer
Device: ETHOS
Radiation: Computed tomography-guided stereotactic adaptive radiotherapy
The Washington University
The Washington University

Saint Louis, Missouri, United States

A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer

Chimeric Degradation Activation Compound (CDAC). BG-60366 is designed to degrade mutant EGFR, which is a common cause for Non-Small Cell Lung...

Active, not recruiting
Lung Cancer
EGFR Mutation-Related Tumors
Drug: BG-60366

Phase 1

BeOne Medicines

St Louis, Missouri, United States and 28 other locations

Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Involvement (NEO-SURG)

by resection and adjuvant cemiplimab in stage 3 non-small cell lung cancer (NSCLC) with contralateral mediastinal or ipsilateral su...

Enrolling
Non-small Cell Lung Cancer Stage III
Drug: Cemiplimab-Rwlc

Phase 2

Georgetown University
Georgetown University

St Louis, Missouri, United States and 2 other locations

Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy

This is a Phase II, multi-site, open-label, parallel group study in participants with untreated extended-stage small-cell lung cancer...

Active, not recruiting
Small-cell Lung Cancer
Extensive-stage Small-cell Lung Cancer
Drug: Paclitaxel
Drug: BNT327 Dose Level 2 (DL2)

Phase 2

BioNTech
BioNTech

Fenton, Missouri, United States and 64 other locations

First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer (FLINN)

inbakicept in patients with stage IV or recurrent non-small cell lung cancer (NSCLC). It is hypothesized that the study treatment w...

Not yet enrolling
Non-small Cell Lung Cancer Stage IV
Non-small Cell Lung Cancer Recurrent
Drug: Ipilimumab
Drug: Nivolumab

Phase 2

The Washington University
The Washington University

St Louis, Missouri, United States

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

HCC is a common cancer worldwide and a leading cause of cancer-related death. Lung cancer is the most frequently ...

Enrolling
Hepatocellular Cancer
Squamous-Cell Non-Small Cell Lung Cancer
Drug: ABBV-324
Drug: Lenvatinib

Phase 1

AbbVie
AbbVie

St Louis, Missouri, United States and 21 other locations

DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer

with atezolizumab in patients with extensive stage small cell lung cancer (ES-SCLC) whose disease has not progressed after initial ...

Begins enrollment in 2 months
Small-cell Lung Cancer
Small Cell Lung Cancer Extensive Stage
Drug: Atezolizumab
Drug: DSP-0390

Phase 1

The Washington University
The Washington University

St Louis, Missouri, United States

An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer

This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small cell lung ...

Active, not recruiting
Non-small Cell Lung Cancer (NSCLC)
Cancer
Drug: Cofetuzumab Pelidotin

Phase 1

AbbVie
AbbVie

St Louis, Missouri, United States and 25 other locations

Clinical trials

Find clinical trialsTrials by location

Research sites

Find research sitesLearn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy NoticeTerms
© Copyright 2026 Veeva Systems